Log in to save to my catalogue

Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression...

Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1514809952

Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes

About this item

Full title

Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes

Publisher

United States: Public Library of Science

Journal title

PloS one, 2014-04, Vol.9 (4), p.e94320

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Recent clinical data have led to the consideration of sexual steroids as new potential therapeutic tools for multiple sclerosis. Selective estrogen receptor modulators can exhibit neuroprotective effects like estrogen, with fewer systemic estrogen side effects than estrogen, offering a more promising therapeutic modality for multiple sclerosis. The...

Alternative Titles

Full title

Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1514809952

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1514809952

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0094320

How to access this item